Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Alessandra Narcisi, Fabrizio Amoruso et al.|Journal of Dermatological Treatment|2024Cited by 21
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patientsGianluca Nazzaro, Angelo Valerio Marzano, Andrea Carugno et al.|International Journal of Dermatology|2024Cited by 18